QCM
VYGR icon

Quantinno Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Quantinno Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Buy
35,703
+4,405
+14% +$17.3K ﹤0.01% 3240
2025
Q4 		$123K Buy
+31,298
New +$138K ﹤0.01% 3111

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quantinno Capital Management's VYGR Position: Q1 2026 in Review

Quantinno Capital Management increased its Voyager Therapeutics (VYGR) stake by 14% in Q1 2026, buying an estimated $17.3K and bringing the position to 35,703 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #3240.

Quantinno Capital Management first reported a position in VYGR in Q4 2025 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Quantinno Capital Management held 35,703 shares of Voyager Therapeutics worth $138K as of Q1 2026.
  • Quantinno Capital Management bought 4,405 Voyager Therapeutics shares in Q1 2026, an estimated $17.3K.
  • Voyager Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3240 holding.
  • Quantinno Capital Management first reported a position in Voyager Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.